富马酸沃诺拉赞，CAS 登记号 1260141-27-2，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 富马酸沃诺拉赞 的 CAS 号：1260141-27-2，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Vonoprazan Fumarate · CAS 1260141-27-2 · C21H20FN3O6S. UNII 4QW3X4AMLB.
| CAS Registry Number | 1260141-27-2 |
|---|---|
| PubChem CID | 45375887 |
| Molecular formula | C21H20FN3O6S |
| IUPAC name | (E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine |
| UNII (FDA) | 4QW3X4AMLB |
| Molecular Weight | 461.5 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Exact Mass | 461.10568470 |
| Monoisotopic Mass | 461.10568470 |
| Topological Polar Surface Area | 147 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 629 |
Vonoprazan Fumarate; 1260141-27-2; TAK-438; 881681-01-2; Vonoprazan fumurate; 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate; TAK 438; TAK438; TAK-438 monofumarate; 2098974-13-9; Vonoprazan Fumarate (TAK-438); 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-N-methyl-1-(3-pyridinylsulfonyl)-, 2-butenedioate (1:1); MFCD18633280; VOQUEZNA; (E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine; 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine xfumarate
CAS 1260141-27-2; molecular formula C21H20FN3O6S; molecular weight — g/mol.
Vonoprazan Fumarate, 1260141-27-2, TAK-438, 881681-01-2, Vonoprazan fumurate, 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.